CHRI is massively under valued because its a China stock and most want no part of it. They may do $70m in 2012 without U.S sales. They now will enter the U.S market thru HBRM and sales may go north of $100m and more investors will want in because they are a U.S company. part anyway
Look @ these earnings and tell me how undervalued CHRI is
China Health Resource Reports on Preliminary Record Fourth Quarter and Year-End 2011 Results; Announces 2012 Earnings Guidance
--2011 record breaking sales and earnings well above Company's expectations -- Revenues expected to increase by $24.7 million or 241% year-over-year to $34.9 million -- Net Income expected to total to $6.8 million, or $0.038 per share for 2011 an increase of approx 150% (total shares over 176 million) -- Company announces earnings guidance for 2012 and establishes a range between $0.06 and $0.065 per share
SICHUAN, China, Feb. 16, 2012 /PRNewswire via COMTEX/ -- China Health Resource, Inc. (OTCBB: CHRI News), today announced expected earnings for the fourth quarter and year ended December 31, 2011, subject to the completion of an independent audit. The company expects 2011 fourth quarter operating revenues of more than $12.5 million, an $8.5 million or a 218% increase over the same period in 2010. For the year, the company anticipates reporting operating revenues of $34.9 million, a 241% increase over 2010 revenues of $10.2 million.
The company expects 2011 fourth quarter net income to be $2.7 million, or $0.015 per fully diluted common share, compared with $1.6 million or $0.01 per share for the fourth quarter of 2010. For the year, the company anticipates net income to be $6.8 million, or $0.038 per fully diluted common share, compared with a net income of $2.7 million, or $0.02 per share in the previous year.
The growth is attributed to expansion of the TCM product lines particularly its premier TCM herbs such as Gastrodiae ("TianMa") and improvements in sales channel management for markets outside of the Sichuan province combined with consistent cost controls.
"We are extremely pleased with the solid results for the fourth quarter and the year," said Jiayin Wang, President and CEO of CHRI. "These results are a reflection of the hard work and commitment of China Health Resource's employees to execution of our company's goals. Based on the 2011 results as well as our continued implementation of our strategic goals this year, we look forward to a very successful 2012."
2012 Earnings Guidance
China Health Resource has issued earnings guidance for 2012. The company's 2012 earnings are estimated to be in the range of $0.06 and $0.065 per share. The company's earnings forecasts are subject to numerous risks, including those described under 'Forward-Looking Statements' below and under 'Risk Factors' in its annual and quarterly reports.
"Speaking to the company's focus in 2012," Wang added, "we will continue to maintain our leadership in our DAR franchise while we grow our product lines with valuable and high growth products like Gastrodiae. In addition, we will pursue growth opportunities worldwide through acquisition and distribution and grow in areas where we can best serve customers and create value."
News 
Market Data 
Discover 
